A traditional medicinal plant, tormentil, shows promise against antibiotic-resistant bacteria in laboratory tests. Its compounds work by limiting bacterial growth and boosting antibiotic performance.
Before the development of modern antibiotics, plant-based remedies were commonly used to treat infections.
One such plant is tormentil (Potentilla erecta), a small yellow wildflower found across Ireland, the UK, and Europe. Its root has a long history in traditional Irish and European medicine, where it was used to treat wounds, sore throats, diarrhea, and gum disease. These longstanding uses hinted that tormentil might contain compounds capable of killing harmful microbes.
Our recent research has now shown that not only does tormentil have antimicrobial activity, it may also be powerful enough to fight microbes that are resistant to modern antibiotics.
Antimicrobial resistance is an increasing global concern. It arises when bacteria adapt in ways that allow them to survive drugs that once killed them. As a result, some infections are becoming extremely difficult, and in some cases impossible, to treat. This trend raises the risk of returning to a time when infections that are now manageable could once again become life-threatening.
Researchers are therefore searching for new antimicrobial compounds. Plants are a promising source, having evolved over millennia to produce a wide range of bioactive chemicals to defend themselves against microbes.

Traditional remedies inspire modern testing
In our recent study, we investigated whether various Irish bogland plants contain compounds that could help fight multidrug-resistant bacteria.
To do this, we prepared extracts from over 70 different plant species collected from bogs across Ireland. We then tested them against clinically relevant bacterial pathogens in the laboratory – including bacteria which cause severe pneumonia and urinary tract infections.
We used antimicrobial susceptibility testing to see whether the extracts inhibited bacterial growth. This involved exposing the bacteria to the various plant extracts to see which extract inhibited the growth of the bacteria.
We then tested these extracts on biofilms to determine whether the plant compounds could prevent bacteria from forming biofilms. Biofilms are bacterial communities surrounded by a slimy carbohydrate shield that protects them from antibiotics, disinfectants, and the immune system.
Tormentil shows strong antimicrobial effects
Excitingly, our initial screening showed that tormentil extracts were antimicrobial and limited the formation of biofilms. This suggested these extracts contained compounds with antimicrobial activity, which may explain their historical use to treat infection.
We also explored whether these plant extracts could work in combination with existing antibiotics, as some plant compounds don't kill bacteria directly but instead can make antibiotics work better. So we combined low levels of the antibiotic colistin – an antibiotic that is only used as a last resort against severe infections due to its potential toxicity to patients – with the tormentil extract. The low-level antibiotic dosage wasn't enough to kill the bacteria when used on its own. But when combined with the tormentil extract, the plant compound enhanced the antibiotic's efficacy.
Part of our team then performed an analysis to identify the compounds present in the tormentil extracts. Potentilla plants are known to contain naturally occurring compounds, such as ellagic acid and agrimoniin, which have antioxidant and anti-inflammatory properties.
We tested ellagic acid and agrimoniin compounds which were present in our bogland tormentil. We showed that these specific compounds could inhibit bacterial growth. This indicates they may be responsible for tormentil's antimicrobial activity.
We subsequently found these compounds were doing this by scavenging iron – a nutrient that's essential for bacterial growth. This effectively starved the bacterial cells, preventing them from growing. We are now focused on optimizing this antimicrobial activity and developing formulations to test its potential as a treatment in experimental models.
Plants offer new paths against resistance
Nature has always been a rich source of medicine. Many antibiotics that we use today originally came from natural sources. For instance, the potent, last-resort antibiotics vancomycin – which is used to treat MRSA (methicillin-resistant Staphylococcus aureus) and C difficile infections – came from soil microbes.
With antimicrobial resistance continuing to rise globally, we urgently need new approaches and treatments. Plants may be an underexplored source of both new antimicrobial compounds and of compounds that make existing drugs more effective.
The story of tormentil shows how nature and traditional medicine can work hand in hand with modern science to address today's challenges. It also highlights that solutions can be found in unexplored places – even in a small yellow wildflower growing in a bogland.
Reference: "Bogland plant Tormentil inhibits multidrug-resistant pathogen growth and potentiates antibiotics by disrupting iron homeostasis" by Kavita Gadar, Maria Pigott, Cillian Jacques Gately, Ismael Obaid, Shipra Nagar, John J. Walsh, Helen Sheridan and Ronan R. McCarthy, 23 March 2026, Microbiology.
DOI: 10.1099/mic.0.001675
Adapted from an article originally published in The Conversation.
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
COVID-19 can wake up dormant viruses in the body, large study confirms
Virus reactivations by SARS-CoV-2 could worsen initial symptoms and increase risk of Long Covid. Early in the COVID-19 pandemic, scientists noticed that a SARS-CoV-2 infection can “wake up” other, dormant viruses already present in [...]
Scientists Discover the Brain May Enter a New Biological Phase Between 50 and 75
A single-cell study reveals major changes in immune cells, genome organization, and gene regulation within the aging human hippocampus, offering important insights into brain aging and dementias associated with age. Between roughly ages 50 [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Unzipping the Code of Life: Scientists Pinpoint Where DNA First Opens
Researchers mapped where DNA first opens and how a helicase gate may release one strand as genome copying begins. Before a cell can divide, it must open its tightly wound DNA and begin copying the entire [...]
Scientists Tested an 8-Hour Eating Window and Found a Surprising Brain Benefit
Limiting the daily eating window may provide brain benefits beyond those associated with weight loss. Eating within a shorter daily window may provide cognitive benefits beyond those associated with weight loss alone, according to [...]
Focused Ultrasound Opens Blood-Brain Barrier to Treat Brain Cancer
Summary: A new study demonstrates that primary brain tumors (gliomas) are particularly receptive to targeted drug delivery using focused ultrasound (FUS) combined with microbubbles. The team developed a high-resolution MRI protocol to track blood-brain barrier [...]
AI’s promise and practical limits in drug discovery
AI tools are becoming increasingly common in early drug discovery, allowing scientists to analyse data and navigate large volumes of research. However, according to Dr Raminderpal Singh, turning that potential into consistent scientific workflows [...]
GHCE Concept
From the preface of the book Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artificial Intelligence, Edited by Frank Boehm: Since the publication of my first book (Nanomedical Device and Systems [...]
Healthcare Headlines: Challenges and Advances in 2026
Health-related updates reveal financial adjustments by Universal Health Services due to Medicaid reimbursement uncertainties, significant pollution-linked health concerns from French-British oil firm Perenco in Congo, drug trial setbacks, potential restructuring at major medical firms, [...]
Scientists Discover the Brain Protein That Helps Alzheimer’s Spread Through the Brain
Scientists have identified a brain protein that may help Alzheimer’s spread, revealing a potential new target for slowing the disease’s progression. Alzheimer’s disease is closely linked to the accumulation of a toxic form of the protein [...]
How Immune Dysregulation Contributes to Psychiatric Disorders
Introduction Growing evidence suggests that disruptions in immune function may play an important role in the development and progression of psychiatric disorders. However, immune mechanisms probably contribute more strongly in some patients than others, [...]
Electrostatic Discharge Boosts Triboelectric Nanogenerator Current and Enables DC Output
Controlled electrical discharges could enable triboelectric nanogenerators to achieve higher peak currents, extending nano-enabled energy harvesting into chemical processing and self-powered sensing. Paper: Electrostatic discharge as a breakthrough strategy for triboelectric nanogenerators. A new review [...]
Swiss laboratory uses old drugs against rare diseases
Researchers at the University of Geneva are combing through collections of approved drugs to find new therapies for rare diseases – with some success. This approach is gaining traction around the world, while pharmaceutical [...]
Nanozyme Aptasensors Show Promise for Faster Food, Health, and Environmental Testing
By pairing robust artificial enzymes with highly selective aptamers, nanozyme aptasensors could help detect disease biomarkers, pathogens, and contaminants faster, but the review shows that real-world deployment still depends on overcoming matrix interference, biofouling, [...]
Paralyzed Man Feels Sensation Again With Brain Stimulation Device
Aneuroprosthetic system has allowed a man with paralysis to grasp and lift objects and feel touch again. The device helped 42-year-old Keith Thomas of Massapequa, New York, who was paralyzed from the chest down [...]
Global Cancer Cases Could Surge 67% by 2050, New Report Warns
New data reveal major geographic disparities and highlight the urgent need for global action on prevention, early detection, and equitable access to treatment. For roughly one in five people worldwide, cancer will become part [...]















